期刊文献+

乳腺癌前哨淋巴结转移的危险因素 被引量:2

Risk factors of sentinel lymph node metastasis
下载PDF
导出
摘要 目的对乳腺癌接受前哨淋巴结活检的患者进行回顾性研究,探讨乳腺癌不同分子分型与前哨淋巴结转移的关系及影响前哨淋巴结转移的危险因素。方法回顾性分析2017年6月至2020年1月于济宁医学院附属医院乳腺外科接受前哨淋巴结活检的192例乳腺癌患者资料,根据雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER-2)的免疫组织化学结果进行分子分型,分析前哨淋巴结转移的危险因素。结果192例乳腺癌患者中,前哨淋巴结阳性52例,阴性140例;Luminal A型SLN转移率17.2%、Luminal B型SLN转移率36.9%、HER-2过表达型SLN转移率45.5%、三阴型SLN转移率16.7%,4种乳腺癌分子分型SLN转移率存在明显统计学差异(χ^(2)=4.818,P=0.028);单因素分析显示HER-2阳性、肿瘤T分期、脉管癌栓浸润等危险因素对前哨淋巴结转移情况的影响存在统计学差异(P<0.05)。logistic回归分析结果显示脉管癌栓浸润及乳腺癌分子分型均是影响前哨淋巴结转移的独立危险因素;Luminal B型及HER-2过表达型乳腺癌发生前哨淋巴结转移风险均高于Luminal A型,差异有统计学意义。结论Luminal B型及HER-2过表达型乳腺癌患者较Luminal A型发生前哨淋巴结转移的风险更高;有脉管癌栓浸润的乳腺癌患者更容易发生前哨淋巴结转移,其他因素的影响有待进一步证实。 Objective A retrospective study was conducted to investigate the relationship between different molecular types of breast cancer and sentinel lymph node biopsy metastasis,and the risk factors influencing sentinel lymph node metastasis.Methods The data of 192 patients with breast cancer who underwent sentinel lymph node biopsy in the department of breast surgery,Affiliated Hospital of Jining Medical University from June 2017 to January 2020 were retrospectively analyzed.According to the immunohistochemical results of estrogen receptor(ER),progesterone receptor(PR)and human epidermal growth factor receptor 2(HER-2),the molecular typing was performed to analyze the risk factors of sentinel lymph node metastasis.Results Among 192 breast cancer patients,52 had positive sentinel lymph nodes and 140 had negative sentinel lymph nodes.Luminal A SLN metastasis rate was 17.2%,Luminal B SLN metastasis rate was 36.9%,HER-2 overexpressed SLN metastasis rate was 45.5%,and SLN metastasis rate was 16.7%.Statistical analysis showed that SLN metastasis rate of the four breast cancer molecular types was significantly different(P<0.05).Univariate analysis showed that there were statistically significant differences in the influence of risk factors such as positive HER-2,tumor T stage,and vascular tumor plug infiltration on sentinel lymph node metastasis(P<0.05).There was no statistically significant difference in the influence of age,BMI,tumor profile,histological grade and other factors on sentinel lymph node metastasis(P>0.05).The results of multivariate regression analysis showed that vascular plug infiltration and breast cancer molecular typing were independent risk factors for sentinel lymph node metastasis.Luminal B and HER-2 overexpressed breast cancer had higher risk of sentinel lymph node metastasis than Luminal A,and the difference was statistically significant.Conclusion Patients with Luminal B and HER-2 overexpressed breast cancer have a higher risk of sentinel lymph node metastasis than patients with Luminal A.Patients with breast cancer with vascular plug infiltration are more likely to have sentinel lymph node metastasis,and the influence of other factors needs to be further confirmed.
作者 刘方超 李建军 LIU Fangchao;LI Jianjun(School of Clinical Medicine,Jining Medical University,Jining 272013,China)
出处 《济宁医学院学报》 2021年第2期89-93,共5页 Journal of Jining Medical University
关键词 乳腺癌 分子分型 前哨淋巴结转移 Breast cancer Molecular typing Sentinel lymph node metastasis
  • 相关文献

参考文献7

二级参考文献64

  • 1陆旭,李波,华彬,韦军民.乳腺癌前哨淋巴结活检临床意义研究[J].中国实用外科杂志,2006,26(11):860-861. 被引量:11
  • 2王晨,张晓琴,魏荣,吴丽然,李欣.乳腺癌淋巴结转移相关因素的多元分析[J].山西医药杂志,2006,35(12):1068-1072. 被引量:5
  • 3Reseigno J, Zampell JC, Axelrod D. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy [ J ].Ann Surg Oncol, 2009,16(3) : 687-696.
  • 4Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axil- lary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 [J].J Clin Oncol,2007,25(24) : 3657-3663.
  • 5Jatoi I.Axillary vs sentinel lymph node dissection for invasive breast cancer[J ]. JAMA, 2011,305(22) : 2288.
  • 6Kumar A, Puri R, Gadgil PV, et al. Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla [J].World J Surg, 2012,36(7): 1453-1459.
  • 7Feldman SM, Sweatman CA Jr. Sentinel node biopsy for breast cancer: past, present, and future (editorial) [J].Ann Surg Oncol, 2012,19(10):3123-3124.
  • 8Gainer SM, Hunt KK, Beitsch P, et al. Changing behavior in clinical practice in response to the ACOSOG Z0011 trial : a survey of the American Society of Breast Surgeons [J].Ann Surg Oncol, 2012,19(10) : 3152-3158.
  • 9Haffty BG, Hunt KK, Harris JR, et al. Positive sentinel nodes without axillary dissection: implications for the radiation oncol- ogist[J].J Clin Oncol, 2011,29(34) :4479-4481.
  • 10Milgrom S, Cody H, Tan L, et al. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mas- tectomy without axillary-specific treatment [J].Ann Surg On- col, 2012,19(12) : 3762-3770.

共引文献1277

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部